Cargando…
Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory autoimmune skin disease. Evidence-based therapy for CLE is lacking in the most part. Intravenous immunoglobulin (IVIg) is being increasingly utilized as off-label therapy for a variety of autoimmune and inflammatory conditions, especially...
Autores principales: | Ky, Christa, Swasdibutra, Brian, Khademi, Shaadi, Desai, Sheetal, Laquer, Vivian, Grando, Sergei A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387332/ https://www.ncbi.nlm.nih.gov/pubmed/25918617 http://dx.doi.org/10.4081/dr.2015.5804 |
Ejemplares similares
-
Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020) -
Intravenous Immunoglobulin for the Rescue in Refractory Cutaneous Lupus
por: Singh, Harpreet, et al.
Publicado: (2020) -
Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil
por: Chow, Kevin W, et al.
Publicado: (2023) -
Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus
por: Binello, Nicolò, et al.
Publicado: (2018) -
Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)